JP2009515939A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009515939A5 JP2009515939A5 JP2008540695A JP2008540695A JP2009515939A5 JP 2009515939 A5 JP2009515939 A5 JP 2009515939A5 JP 2008540695 A JP2008540695 A JP 2008540695A JP 2008540695 A JP2008540695 A JP 2008540695A JP 2009515939 A5 JP2009515939 A5 JP 2009515939A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- neuropathic pain
- galanin
- nerve
- injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0523550.2 | 2005-11-18 | ||
| GBGB0523550.2A GB0523550D0 (en) | 2005-11-18 | 2005-11-18 | Therapeutic uses of steroidal compounds |
| PCT/GB2006/004305 WO2007057691A2 (en) | 2005-11-18 | 2006-11-17 | Therapeutic uses of steroidal compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009515939A JP2009515939A (ja) | 2009-04-16 |
| JP2009515939A5 true JP2009515939A5 (https=) | 2012-11-08 |
| JP5395437B2 JP5395437B2 (ja) | 2014-01-22 |
Family
ID=35580318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008540695A Expired - Fee Related JP5395437B2 (ja) | 2005-11-18 | 2006-11-17 | ステロイド化合物の治療使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8846652B2 (https=) |
| EP (1) | EP1948192A2 (https=) |
| JP (1) | JP5395437B2 (https=) |
| KR (1) | KR101314694B1 (https=) |
| CN (1) | CN101346144B (https=) |
| AU (1) | AU2006314226B2 (https=) |
| CA (1) | CA2630441C (https=) |
| GB (1) | GB0523550D0 (https=) |
| IL (1) | IL191457A (https=) |
| MX (1) | MX2008006440A (https=) |
| NO (1) | NO20082741L (https=) |
| NZ (1) | NZ568560A (https=) |
| RU (1) | RU2427375C2 (https=) |
| TW (1) | TWI386211B (https=) |
| WO (1) | WO2007057691A2 (https=) |
| ZA (1) | ZA200804266B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU20110244A7 (es) | 2011-12-27 | 2013-08-29 | Ct De Investigación Y Desarrollo De Medicamentos Cidem | Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios |
| CN108434090A (zh) * | 2017-02-14 | 2018-08-24 | 高药品股份有限公司 | 以生理脂肪为基剂的类固醇药膏 |
| RU2745868C9 (ru) * | 2020-05-28 | 2021-04-08 | Федеральное государственное бюджетное образовательное учреждение высшего образования «Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва» | Способ ускорения регенерационных процессов в поврежденных периферических нервах |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992012997A1 (en) | 1991-01-16 | 1992-08-06 | The General Hospital Corporation | Human galanin |
| WO1992015015A1 (en) | 1991-02-25 | 1992-09-03 | Zymogenetic, Inc. | Methods for detecting galanin antagonists |
| DE69225706T2 (de) | 1991-03-06 | 1998-11-26 | Garvan Institute Of Medical Research, Darlinghurst, Neu Sued Wales/New South Wales | Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen |
| SE9101472D0 (sv) | 1991-05-15 | 1991-05-15 | Trion Forskning & Utveckling | Galanin antagonist |
| JPH06172387A (ja) | 1992-12-11 | 1994-06-21 | Aibaitsu Kk | 合成ペプチド誘導体 |
| EP0698612B1 (en) * | 1993-05-18 | 2001-07-25 | Ltt Institute Co., Ltd. | Osteogenesis promoter and osteoporosis remedy |
| JPH09151197A (ja) * | 1995-11-29 | 1997-06-10 | L T T Kenkyusho:Kk | 自己免疫疾患治療薬 |
| DE69739760D1 (de) | 1996-07-24 | 2010-03-25 | Neurotargets Ltd | Verwendung eines Galanin-agonisten in der Herstellung eines Medikaments zur Verbesserung des Gedächtnisses und anderer cognitiver Funktionen |
| JP2000169374A (ja) * | 1998-12-03 | 2000-06-20 | Ltt Kenkyusho:Kk | Ｉｇｆ増強剤 |
| TR200200406T2 (tr) * | 1999-06-11 | 2002-06-21 | Watson Pharmaceuticals, Inc. | Kadınlara oral olmayan yollarla androjenik steroidlerin uygulanması |
| DE10054294A1 (de) * | 2000-11-02 | 2002-05-16 | Heinrich Wieland | Topische Behandlung bei der Mastalgie |
| GB0105772D0 (en) * | 2001-03-08 | 2001-04-25 | Sterix Ltd | Use |
| DE60120104T2 (de) | 2001-03-20 | 2006-09-21 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz |
| WO2002096934A1 (en) | 2001-05-25 | 2002-12-05 | Kemia, Inc. | Non-natural galanin receptor ligands |
| DK1406606T3 (da) | 2001-07-16 | 2007-03-05 | Ortho Mcneil Pharm Inc | Carbamatforbindelser til forebyggelse eller behandling af neuropatisk smerte og smerte forbundet med klynge- og migrænehovedpine |
| JP2004538305A (ja) | 2001-07-31 | 2004-12-24 | ファルマシア・アンド・アップジョン・カンパニー | ３−ヘテロシクリル−及び３−シクロアルキル−３−アリールオキシプロパンアミンによる慢性疼痛の治療 |
| WO2003011272A1 (en) | 2001-07-31 | 2003-02-13 | Pharmacia & Upjohn Company | Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| ATE332688T1 (de) | 2001-10-16 | 2006-08-15 | Endo Pharmaceuticals Inc | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung |
| GB0403509D0 (en) | 2004-02-17 | 2004-03-24 | Neuro Targets Ltd | Galanin receptors and brain injury |
| US20070231373A1 (en) * | 2004-04-28 | 2007-10-04 | Hunter-Fleming Limited | Transdermal Steriod for Formulation |
| JP5449775B2 (ja) * | 2005-10-19 | 2014-03-19 | チャバフ ピーティーワイ エルティーディー | 乳癌の治療に使用されるアロマターゼ阻害薬による副作用の低減 |
| WO2008065408A2 (en) | 2006-11-30 | 2008-06-05 | Hunter-Fleming Limited | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
-
2005
- 2005-11-18 GB GBGB0523550.2A patent/GB0523550D0/en not_active Ceased
-
2006
- 2006-11-17 KR KR1020087014690A patent/KR101314694B1/ko not_active Expired - Fee Related
- 2006-11-17 WO PCT/GB2006/004305 patent/WO2007057691A2/en not_active Ceased
- 2006-11-17 NZ NZ568560A patent/NZ568560A/en not_active IP Right Cessation
- 2006-11-17 RU RU2008124834/15A patent/RU2427375C2/ru not_active IP Right Cessation
- 2006-11-17 JP JP2008540695A patent/JP5395437B2/ja not_active Expired - Fee Related
- 2006-11-17 US US12/094,079 patent/US8846652B2/en not_active Expired - Fee Related
- 2006-11-17 AU AU2006314226A patent/AU2006314226B2/en not_active Ceased
- 2006-11-17 EP EP06808592A patent/EP1948192A2/en not_active Withdrawn
- 2006-11-17 MX MX2008006440A patent/MX2008006440A/es active IP Right Grant
- 2006-11-17 CN CN2006800486827A patent/CN101346144B/zh not_active Expired - Fee Related
- 2006-11-17 CA CA2630441A patent/CA2630441C/en not_active Expired - Fee Related
- 2006-11-20 TW TW095142777A patent/TWI386211B/zh not_active IP Right Cessation
-
2008
- 2008-05-15 IL IL191457A patent/IL191457A/en not_active IP Right Cessation
- 2008-05-16 ZA ZA200804266A patent/ZA200804266B/xx unknown
- 2008-06-17 NO NO20082741A patent/NO20082741L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sikiric et al. | Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications | |
| CN105073110A (zh) | 通过诱导分化成调节性t细胞和促进调节性t细胞增殖来抑制免疫应答的药物组合物 | |
| Wang et al. | Human breast milk-derived exosomes protect against intestinal ischemia and reperfusion injury in neonatal rats | |
| AU2003250892B2 (en) | Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors | |
| US20220340659A1 (en) | Activity Modulator | |
| CN1203861C (zh) | 含有人参皂甙Rb1的脑血管再生/再造促进剂和继发性神经组织变性抑制剂 | |
| US20160015770A1 (en) | Compositions for treatment of retinal detachment | |
| EP3856187A1 (en) | Infigratinib for treatment of fgfr3-related skeletal diseases during pregnancy | |
| TWI414298B (zh) | 前列腺素／環氧化酵素之代謝路徑的調節 | |
| JP5395437B2 (ja) | ステロイド化合物の治療使用 | |
| McNeil et al. | Reversal of ethanol and indomethacin‐induced suppression of hepatic DNA synthesis by 16, 16‐dimethyl prostaglandin E2 | |
| JP2009515939A5 (https=) | ||
| PT1737490E (pt) | Processos de tratamento da aterosclerose | |
| JP4942905B2 (ja) | 神経保護活性を有する７−ヒドロキシエピアンドロステロン | |
| JP2023503413A (ja) | 脳卒中または脳卒中による後遺症治療のためのシルデナフィル及びｒｏｃｋ阻害剤の用途 | |
| CN116115760A (zh) | Eed抑制剂在制备治疗神经免疫性疾病药物中的应用 | |
| RU2721282C2 (ru) | Способ лечения рассеянного склероза (варианты) | |
| KR101277873B1 (ko) | Ｎｉｎｊｕｒｉｎ 활성 억제제를 포함하는 신경세포 또는 내피세포 재생용 조성물 | |
| EP3700534B1 (en) | Methods of treating phelan mcdermid syndrome using farnesyl dibenzodiazepinones | |
| WO2007123234A1 (ja) | 抗てんかん作用増強剤 | |
| Tong et al. | GHRHR Deficiency Enhances Retinal Ganglion Cell Survival and Visual Functions in Experimental Glaucoma by Inhibiting Ferroptosis | |
| CN104436166A (zh) | 神经生长因子在制备治疗脊髓损伤药物中的应用 | |
| HK40060507B (zh) | 包含环（组氨酸-脯氨酸）二肽及甲状旁腺激素的组合物用於预防、改善或治疗骨质流失疾病的用途 | |
| HK40032147A (en) | Activity modulator |